Suxibuzone

琥布宗

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSuxibuzone
Drug Alias Namesuxibuzona琥保松suxibuzonesuxibuzonum
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeM02AA22
Related LinksWikipediaKEGG